drugset / Trial / NCT01125904

A Study To Investigate The Taste Of Crizotinib Liquid In Trained Healthy Adult Volunteers

NCT01125904

Phase 1 Completed 5 enrolled Pfizer
Non-randomizedSingle-groupOpen-label

Summary

An oral-liquid, pediatric form of crizotinib designed for use by pediatric patients is being tested for its' palatability in adults.

Timeline

Start
2010-06
Primary completion
2010-06
Completion
2010-06

Drugs

EvaluationDrugModalityDoseRoute
Background Crizotinib Small molecule Oral

Indications

No indication recorded.